Differences between T cell-type and natural killer cell-type chronic active Epstein-Barr virus infection

被引:114
作者
Kimura, H
Hoshino, Y
Hara, S
Sugaya, N
Kawada, J
Shibata, Y
Kojima, S
Nagasaka, T
Kuzushima, K
Morishima, T
机构
[1] Nagoya Univ, Grad Sch Med, Dept Pediat, Showa Ku, Nagoya, Aichi 4668550, Japan
[2] Nagoya Univ, Grad Sch Med, Dept Clin Pathol, Showa Ku, Nagoya, Aichi 4668550, Japan
[3] Nagoya Univ, Sch Hlth Sci, Dept Nursing, Nagoya, Aichi, Japan
[4] Aichi Canc Ctr, Res Inst, Div Immunol, Nagoya, Aichi 464, Japan
基金
日本学术振兴会;
关键词
D O I
10.1086/427239
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Infections of T cells and natural killer (NK) cells play a central role in the pathogenesis of chronic active Epstein-Barr virus (CAEBV) infection. To characterize the virologic and cytokine profiles of T cell-type and NK cell-type infection, 39 patients with CAEBV infection were analyzed. Patients with T cell-type infection had higher titers of immunoglobulin G against early and late EBV antigens, suggesting lytic cycle infection. However, the pattern of EBV gene expression was latency type II; BZLF1, which is a hallmark of lytic cycle infection, could not be detected in any patients, regardless of infection type. Patients with CAEBV infection had high concentrations of proinflammatory, T helper cell type 1, and anti-inflammatory cytokines. The cytokine profile in patients with NK cell-type infection was similar to that in patients with T cell-type infection, but the concentration of IL-13 was high in patients with NK cell-type infection. These findings should help to clarify the pathogenesis of CAEBV infection and facilitate the development of more-effective treatments.
引用
收藏
页码:531 / 539
页数:9
相关论文
共 55 条
[11]  
420::AID-JMV16&gt
[12]  
3.0.CO
[13]  
2-T
[14]   T-CELL LYMPHOMAS CONTAINING EPSTEIN-BARR VIRAL-DNA IN PATIENTS WITH CHRONIC EPSTEIN-BARR VIRUS-INFECTIONS [J].
JONES, JF ;
SHURIN, S ;
ABRAMOWSKY, C ;
TUBBS, RR ;
SCIOTTO, CG ;
WAHL, R ;
SANDS, J ;
GOTTMAN, D ;
KATZ, BZ ;
SKLAR, J .
NEW ENGLAND JOURNAL OF MEDICINE, 1988, 318 (12) :733-741
[15]   Syndrome of peripheral blood T-cell infection with Epstein-Barr virus (EBV) followed by EBV-positive T-cell lymphoma [J].
Kanegane, H ;
Bhatia, K ;
Gutierrez, M ;
Kaneda, H ;
Wada, T ;
Yachie, A ;
Seki, H ;
Arai, T ;
Kagimoto, S ;
Okazaki, M ;
Oh-ishi, T ;
Moghaddam, A ;
Wang, F ;
Tosato, G .
BLOOD, 1998, 91 (06) :2085-2091
[16]   Interleukin 13 is secreted by and stimulates the growth of Hodgkin and Reed-Sternberg cells [J].
Kapp, U ;
Yeh, WC ;
Patterson, B ;
Elia, AJ ;
Kägi, D ;
Ho, A ;
Hessel, A ;
Tipsword, M ;
Williams, A ;
Mirtsos, C ;
Itie, A ;
Moyle, M ;
Mak, TW .
JOURNAL OF EXPERIMENTAL MEDICINE, 1999, 189 (12) :1939-1945
[17]   Differential cellular targets of Epstein-Barr virus (EBV) infection between acute EBV-associated hemophagocytic lymphohistiocytosis and chronic active EBV infection [J].
Kasahara, Y ;
Yachie, A ;
Takei, K ;
Kanegane, C ;
Okada, K ;
Ohta, K ;
Seki, H ;
Igarashi, N ;
Maruhashi, K ;
Katayama, K ;
Katoh, E ;
Terao, G ;
Sakiyama, Y ;
Koizumi, S .
BLOOD, 2001, 98 (06) :1882-1888
[18]   Systemic cytokine responses in patients with influenza-associated encephalopathy [J].
Kawada, J ;
Kimura, H ;
Ito, Y ;
Hara, S ;
Iriyama, M ;
Yoshikawa, T ;
Morishima, T .
JOURNAL OF INFECTIOUS DISEASES, 2003, 188 (05) :690-698
[19]   EPSTEIN-BARR-VIRUS INFECTED T-LYMPHOCYTES IN EPSTEIN-BARR-VIRUS ASSOCIATED HEMOPHAGOCYTIC SYNDROME [J].
KAWAGUCHI, H ;
MIYASHITA, T ;
HERBST, H ;
NIEDOBITEK, G ;
ASADA, M ;
TSUCHIDA, M ;
HANADA, R ;
KINOSHITA, A ;
SAKURAI, M ;
KOBAYASHI, N ;
MIZUTANI, S .
JOURNAL OF CLINICAL INVESTIGATION, 1993, 92 (03) :1444-1450
[20]   CD3-NEGATIVE LYMPHOPROLIFERATIVE DISEASE OF GRANULAR LYMPHOCYTES CONTAINING EPSTEIN-BARR VIRAL-DNA [J].
KAWAHA, K ;
ISHIHARA, S ;
NINOMIYA, T ;
YUMURAYAGI, K ;
HARA, J ;
MURAYAMA, F ;
TAWA, A ;
HIRAI, K .
JOURNAL OF CLINICAL INVESTIGATION, 1989, 84 (01) :51-55